Congratulations to Associate Professor Bernard Flynn and the collaborators on the establishment of a spin-off company to further develop fibrosis therapeutics that have potential to treat many diseases. Associate Professor Flynn was supported by NFMRI and is another example of how NFMRI’s strategy assists biomedical research and innovations advance towards delivering community benefits. Australian biotech […]VIEW POST
Australia’s innovation efficiency is a wicked problem needing a solution. The ability for Australia to capitalise on its research efforts has consistently ranked well below expectations. One of the key opportunities for philanthropy is to innovate and test solutions that can be scaled to assist in solving wicked problems such as this and contribute towards […]VIEW POST
Bridging the Valley-of-Death to Create a Path to Successes, a Case for Publically Funded Drug Discovery.
Written by Associate Professor Bernard Flynn The Opportunity: The pharmaceutical sector is one of the most profitable industries in the world. The top 10 selling drugs all have annual sales in excess of US$6 bil pa. In the last 20 yrs the sector has been transformed, with many larger Pharma companies preferring to build […]VIEW POST
I started writing this post to provoke a conversation and scratch the surface on an important issue. There are many differing points of view and most are valid, and less valid at the same time depending on the lens you are looking through. Measuring impact from research requires a more sophisticated or complex conversation than […]VIEW POST
Rob McInnes, Partner, DibbsBarker Seeking Impact and RoI: Differences and Similarities in Philanthropic, Investor & Public FundingVIEW POST
Dan Baker, M.D., Disease Area Stronghold Leader, Rheumatoid Arthritis, Janssen Research & Development talks about translating biomedical research.VIEW POST
by Philippa Lewis There is constant noise across Australia when it comes to innovation, start-ups and technology especially in healthcare. Blogs abound, meetups and accelerators are in orbit, researchers have never been more inspired, corporates are anxious not to miss out and governments are trying to navigate their methods of contribution and justify their electoral pitches. […]VIEW POST
The ‘halo effect’ can be both a positive and negative for funders of research. How does it affect you?
A challenge for funders of research is that it often requires more than research to achieve their ultimate goals. Restricting funding to research is often set out in the terms of; a bequest, a donation, a grant, the constitution and may be a requirement for the funder to maintain charitable status. The outcome funders wish […]VIEW POST
Could this be a reality? We all know that not all good ideas gain traction and become reality. This is true for inventors, for business, for things around the home and for medical research. Discoveries and good ideas that are never disclosed and disappear without a trace may later be rediscovered and lead to future […]VIEW POST
A few weeks ago, we held our inaugural medical research and innovation conference, “Putting Rubber on the Road”, in Sydney. The conference was launched by Mr Paul Clitheroe AM, who coined this title when we introduced and discussed the role, strategy and approach of our Foundation. The concept of our inaugural conference came about after […]VIEW POST